Updated Jul 16, 2026
Burdick Kenneth A has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $498K. Lifetime open-market sales: $7.74M. Historical track record: 5/5 stars across 5 tracked purchases.
Kenneth A. Burdick is a corporate executive known for his role as a director at Centene Corporation and LifeStance Health Group, Inc. He has extensive experience in the healthcare sector, particularly in managed care organizations.
| Role | Insider |
|---|---|
| Notability | 50/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +1833.63% |
| Avg 30-day return | +2227.68% |
| Avg 90-day return | +4209.24% |
| Best 30-day return | +2837.53% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | LFST | LifeStance Health Group, Inc. | A — Grant or award | 45.5K | $0.00 | |
| 2026-06-11 | CNC | CENTENE CORP | S — Open-market sale | 80.0K | $64.55 | $5.16M |
| 2026-05-13 | CNC | CENTENE CORP | A — Grant or award | 4.0K | $0.00 | |
| 2026-03-11 | LFST | LifeStance Health Group, Inc. | F — Tax withholding / forfeiture | 278.2K | $6.91 | $1.92M |
| 2026-03-11 | LFST | LifeStance Health Group, Inc. | A — Grant or award | 707.0K | $0.00 | |
| 2026-03-11 | LFST | LifeStance Health Group, Inc. | F — Tax withholding / forfeiture | 13.2K | $6.91 | $91K |
| 2026-03-11 | LFST | LifeStance Health Group, Inc. | A — Grant or award | 33.5K | $0.00 | |
| 2026-03-11 | LFST | LifeStance Health Group, Inc. | F — Tax withholding / forfeiture | 35.8K | $6.91 | $247K |
| 2026-03-10 | LFST | LifeStance Health Group, Inc. | F — Tax withholding / forfeiture | 424.6K | $7.11 | $3.02M |
| 2025-12-05 | CNC | CENTENE CORP | S — Open-market sale | 32.8K | $39.00 | $1.28M |
| 2025-12-05 | CNC | CENTENE CORP | S — Open-market sale | 33.2K | $39.04 | $1.30M |
| 2025-09-30 | CNC | CENTENE CORP | A — Grant or award | 852 | $0.00 | |
| 2025-08-08 | LFST | LifeStance Health Group, Inc. | P — Open-market purchase | 46.5K | $4.30 | $200K |
| 2025-08-08 | LFST | LifeStance Health Group, Inc. | P — Open-market purchase | 18.7K | $4.54 | $85K |
| 2025-08-08 | LFST | LifeStance Health Group, Inc. | P — Open-market purchase | 1.3K | $4.35 | $6K |
| 2025-08-08 | LFST | LifeStance Health Group, Inc. | P — Open-market purchase | 1.8K | $4.31 | $8K |
| 2025-08-08 | LFST | LifeStance Health Group, Inc. | P — Open-market purchase | 45.9K | $4.36 | $200K |
| 2025-06-30 | CNC | CENTENE CORP | A — Grant or award | 556 | $0.00 | |
| 2025-05-13 | CNC | CENTENE CORP | A — Grant or award | 3.6K | $0.00 | |
| 2025-03-31 | CNC | CENTENE CORP | A — Grant or award | 500 | $0.00 |
Kenneth A. Burdick is a corporate executive known for his role as a director at Centene Corporation and LifeStance Health Group, Inc. He has extensive experience in the healthcare sector, particularly in managed care organizations.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 5 open-market purchases ($498K) and 3 open-market sales ($7.74M) across all tracked filings.
Across 5 tracked purchases, Burdick Kenneth A averaged +2227.7% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burdick Kenneth A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.